iGenomX International Genomics Corp

Businessfiled

iGenomX International Genomics Corp operates in Biotech, based in CARLSBAD.

Sub-sector tags: biotech.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

iGenomX International Genomics Corp has raised $5.1M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $3.0M on 2015-11-25.

Most recent recorded round closed around 2019-04-12.

Valuation (modeled)modeled

Provath models iGenomX International Genomics Corp at approximately $67M (range $1.1M–$523M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.76× the median modeled value of Seed Biotech companies in 2019–2021 (7 peers) — value vs value, same stage and era. Within the normal band (76% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 20 months.

Last raise 7.2 yr ago; this sector typically re-raises about every 11 months.

Silent for over 3× the sector's normal cadence.

The last round was 2.5× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 80% of Biotech peers (233 compared).

Modeled value ranks above 84% of those peers.

Closest niche peers: Orpheus Bioscience, Inc., OneThree Biotech, Inc., Phloem Biotech, Inc., Meridian Biotech, LLC, Sixfold Bioscience Inc..

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.